Analytical Data
-
Gene name
ORF11
- Application
-
Species
Varicella-zoster virus
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P09263
-
Expression Region
354-808aa
-
Molecular Weight
58.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of ORF11 recombinant protein has gained significant attention due to its potential implications in understanding viral pathogenesis and immune response mechanisms, particularly in the context of coronavirus research. ORF11, a gene found in various viral genomes, including those of coronaviruses like SARS-CoV-2, is implicated in modulating host cell interactions and immune evasion. Understanding the functional properties of the ORF11 protein can provide insights into its role in the viral life cycle and its interactions with the host immune system. Researchers are utilizing recombinant DNA technology to express and purify ORF11 proteins for detailed biochemical and structural analyses. These studies aim to elucidate the protein's function, stability, and potential as a target for therapeutic interventions. Given the rapid evolution of coronaviruses and the emergence of new variants, investigating the ORF11 protein can contribute to vaccine design and the development of antiviral strategies. Additionally, this research addresses broader questions related to viral evolution, host-pathogen interactions, and the mechanisms underlying viral pathogenesis, thereby enhancing our understanding of infectious diseases and informing public health responses. Overall, the exploration of ORF11 recombinant proteins not only aims to uncover specific viral mechanisms but also seeks to provide foundational knowledge that can help combat future viral outbreaks.
